NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Appropriations History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Appropriations | ₹258 Cr | ₹218 Cr | ₹199 Cr | ₹150 Cr | ₹95 Cr |
What is the latest Appropriations of NGL FINECHEM ?
Year | Appropriations |
---|---|
Mar2024 | ₹258 Cr |
Mar2023 | ₹218 Cr |
Mar2022 | ₹199 Cr |
Mar2021 | ₹150 Cr |
Mar2020 | ₹95 Cr |
How is Appropriations of NGL FINECHEM Trending?
Years | Appropriations | % Change | |
---|---|---|---|
Mar2024 | ₹258 Cr | 18.36 | |
Mar2023 | ₹218 Cr | 9.71 | |
Mar2022 | ₹199 Cr | 32.45 | |
Mar2021 | ₹150 Cr | 58.25 | |
Mar2020 | ₹95 Cr | - |
Compare Appropriations of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹791.2 Cr | -11.5% | 27.6% | -49% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,620.0 Cr | -1.3% | 1% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,509.0 Cr | -3.2% | -0.3% | 48% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,571.0 Cr | 1.2% | 10.7% | 19.5% | Stock Analytics | |
CIPLA | ₹118,336.0 Cr | -0.6% | -2.2% | -0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,522.0 Cr | -1.5% | -5.9% | -5.1% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -11.5% |
27.6% |
-49% |
SENSEX | -0.5% |
-0.3% |
1% |
You may also like the below Video Courses